Latest News and Press Releases
Want to stay updated on the latest news?
-
Dublin, April 15, 2026 (GLOBE NEWSWIRE) -- The "Pharmacovigilance Aspects of Licensing Agreements (June 25, 2026)" training has been added to ResearchAndMarkets.com's offering.This intensive...
-
At AACR 2026, Callio Therapeutics will present data that highlight the potential of CLIO-8221 as a therapeutic option for HER2-expressing cancers
-
– Advancing a broad portfolio designed to deliver multiple paradigm-shifting therapies for devastating and underserved immune-mediated diseases – – Lead program afimetoran, a potential...
-
Dublin, April 14, 2026 (GLOBE NEWSWIRE) -- The "AI in Pharmacovigilance (May 18, 2026)" training has been added to ResearchAndMarkets.com's offering.This course will provide a comprehensive...
-
Dublin, April 14, 2026 (GLOBE NEWSWIRE) -- The "Pharmacovigilance: An Overview of Drug Safety from Safety Collection to Regulatory Inspection (Apr 30, 2026)" training has been added to ...
-
Dublin, April 13, 2026 (GLOBE NEWSWIRE) -- The "NRG Fusion - Competitive Landscape, 2026" has been added to ResearchAndMarkets.com's offering. The report delivers in-depth analysis on the...
-
NEW YORK, April 08, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine...
-
Dublin, April 08, 2026 (GLOBE NEWSWIRE) -- The "Pharmacovigilance Market - Global Forecast 2026-2032" report has been added to ResearchAndMarkets.com's offering. The Pharmacovigilance Market...
-
Tevogen advances TVGN 489 for Long COVID, expanding HLA coverage to 65% of U.S. population and integrating digital monitoring capabilities.
-
NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- Medidata, a Dassault Systèmes brand and global leader in clinical trial solutions, today unveiled a transformative vision for the life sciences industry at...